Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY	$ 28,933			$ 24,905	$ 28,933	$ 25,572
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)		$ (700)
Business Combination, Contingent Consideration, Other change in amount	11
Business Combination, Consideration Transferred, Liabilities Incurred				55,158
Currency translation on earn-out	1	$ 33	$ (98)	(46)
Foreign Infusion System Supplier
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY							$ 2,589
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	1,700
Business Combination, Consideration Transferred, Liabilities Incurred				1,600
SmithsMedical
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	2,300		(27,194)
Business Combination, Consideration Transferred, Liabilities Incurred				53,500	$ 53,520
Smiths Medical & Foreign Infusion Systems Supplier
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY			$ 30,409	$ 57,701
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ 4,016